{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:46Z","timestamp":1792801606668,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112331","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T21:44:01Z","timestamp":1716500641000},"page":"112331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-8335","authenticated-orcid":false,"given":"Masaya","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Shimora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukino","family":"Nagatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itomi","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenta","family":"Haguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-6135","authenticated-orcid":false,"given":"Kazuyuki","family":"Kitatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1211-0410","authenticated-orcid":false,"given":"Osamu","family":"Kaminuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5225-8375","authenticated-orcid":false,"given":"Takeshi","family":"Nabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112331_b0005","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.173.5.3287","article-title":"CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration","volume":"173","author":"Algood","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/088922299310575","article-title":"Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection","volume":"15","author":"Fraziano","year":"1999","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.intimp.2024.112331_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9440(10)64378-7","article-title":"Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes","volume":"160","author":"Kunkel","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2024.112331_b0020","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.166.7.4697","article-title":"Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice","volume":"166","author":"Mack","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0025","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.4049\/jimmunol.176.8.4968","article-title":"Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling","volume":"176","author":"Ma","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1159\/000490024","article-title":"The CCL5\/CCR5 axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching","volume":"47","author":"Lin","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2024.112331_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2013.10.006","article-title":"The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer","volume":"352","author":"Weitzenfeld","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.112331_b0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V99.4.1237","article-title":"The role of CC chemokine receptor 5 in antiviral immunity","volume":"99","author":"Nansen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112331_b0045","first-page":"669","article-title":"Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS","volume":"8","author":"Meanwell","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.intimp.2024.112331_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.intimp.2024.112331_b0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2796.2003.01230.x","article-title":"Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis","volume":"254","author":"Katchar","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2024.112331_b0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/labinvest.3700189","article-title":"Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn\u2019s disease: a pivotal site of Th1-shifted immune response?","volume":"85","author":"Oki","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2024.112331_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2004.02618.x","article-title":"The lung cytokine microenvironment influences molecular events in the lymph nodes during Th1 and Th2 respiratory mucosal sensitization to antigen in vivo","volume":"138","author":"Ritz","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0070","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(99)03425-X","article-title":"Association of CCR5 delta32 with reduced risk of asthma","volume":"354","author":"Hall","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112331_b0075","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(00)03144-5","article-title":"Delta 32 deletion of CCR5 gene and association with asthma or atopy","volume":"356","author":"Mitchell","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112331_b0080","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1165\/rcmb.2010-0465OC","article-title":"Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation","volume":"45","author":"Fuchimoto","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112331_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1096\/fj.01-0528fje","article-title":"The role of CC chemokine receptor 5 (CCR5) and RANTES\/CCL5 during chronic fungal asthma in mice","volume":"16","author":"Schuh","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.112331_b0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1165\/rcmb.2005-0314OC","article-title":"Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness","volume":"34","author":"Walker","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112331_b0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#","article-title":"Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo","volume":"31","author":"de Lavareille","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365540310017087","article-title":"Increased in vitro replication of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates in Th2 lymphocytes may correlate with AIDS progression","volume":"36","author":"Ofori","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112331_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174732","article-title":"Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice","volume":"916","author":"Matsuda","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112331_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.923235","article-title":"The emerging roles of interstitial macrophages in pulmonary fibrosis: A perspective from scRNA-seq analyses","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/rcmb.2016-0361OC","article-title":"Three unique interstitial macrophages in the murine lung at steady state","volume":"57","author":"Gibbings","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112331_b0120","doi-asserted-by":"crossref","first-page":"5160794","DOI":"10.1155\/2018\/5160794","article-title":"Lung interstitial macrophages: Past, present, and future","volume":"2018","author":"Schyns","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2024.112331_b0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2005.08.015","article-title":"Induction of a late asthmatic response associated with airway inflammation in mice","volume":"521","author":"Nabe","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112331_b0130","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.lfs.2011.04.003","article-title":"Important role of neutrophils in the late asthmatic response in mice","volume":"88","author":"Nabe","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.112331_b0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1254\/jphs.11083FP","article-title":"Complete dependence on CD4+ cells in late asthmatic response, but limited contribution of the cells to airway remodeling in sensitized mice","volume":"116","author":"Nabe","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2024.112331_b0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bph.12154","article-title":"Roles of basophils and mast cells infiltrating the lung by multiple antigen challenges in asthmatic responses of mice","volume":"169","author":"Nabe","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112331_b0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2015.03.015","article-title":"Production of interleukin (IL)-33 in the lungs during multiple antigen challenge-induced airway inflammation in mice, and its modulation by a glucocorticoid","volume":"757","author":"Nabe","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112331_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109037","article-title":"Local IL-10 replacement therapy was effective for steroid-insensitive asthma in mice","volume":"110","author":"Matsuda","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112331_b0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbi.2017.11.006","article-title":"CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward","volume":"69","author":"Gonek","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2024.112331_b0160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2024.112331_b0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2018.03.007","article-title":"Increased expression of CysLT2 receptors in the lung of asthmatic mice and role in allergic responses","volume":"131","author":"Matsuda","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.intimp.2024.112331_b0170","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1096\/fj.201903086RR","article-title":"Myeloid-specific blockade of Notch signaling alleviates murine pulmonary fibrosis through regulating monocyte-derived Ly6clo MHCIIhi alveolar macrophages recruitment and TGF-\u03b2 secretion","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.112331_b0175","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1007\/s00018-018-2899-4","article-title":"Fibroblast-to-myofibroblast transition in bronchial asthma","volume":"75","author":"Michalik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2024.112331_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107839","article-title":"Therapeutic targets in lung tissue remodelling and fibrosis","volume":"225","author":"Liu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.112331_b0185","doi-asserted-by":"crossref","first-page":"eaao6152","DOI":"10.1126\/scisignal.aao6152","article-title":"G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs","volume":"11","author":"Lorenzen","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2024.112331_b0190","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1074\/jbc.M110.168955","article-title":"New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection","volume":"286","author":"Garcia-Perez","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112331_b0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaci.2021.05.044","article-title":"Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation","volume":"149","author":"Gauthier","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaci.2023.02.028","article-title":"CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma","volume":"152","author":"Gauthier","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2013-0086MA","article-title":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung","volume":"49","author":"Misharin","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112331_b0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1165\/rcmb.2016-0147OC","article-title":"Lrp5\/\u03b2-catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis","volume":"56","author":"Sennello","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2024.112331_b0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1126\/science.1133515","article-title":"Dendritic Cell Stimulation by Mycobacterial Hsp70 Is Mediated Through CCR5","volume":"314","author":"Floto","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112331_b0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/384179a0","article-title":"CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5","volume":"384","author":"Wu","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112331_b0225","doi-asserted-by":"crossref","first-page":"e72772","DOI":"10.1371\/journal.pone.0072772","article-title":"Induction of TGF-\u03b21 synthesis by macrophages in response to apoptotic cells requires activation of the scavenger receptor CD36","volume":"8","author":"Xiong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112331_b0230","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1164\/rccm.200401-002OC","article-title":"Enhanced monocyte chemoattractant protein-3\/CC chemokine ligand-7 in usual interstitial pneumonia","volume":"170","author":"Choi","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.112331_b0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3\u03b1 Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2024.112331_b0240","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.4049\/jimmunol.1001039","article-title":"IL-27\/IFN-\u03b3 induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112331_b0245","first-page":"2383","article-title":"The TLR and IL-1 signalling network at a glance","volume":"127","author":"Cohen","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.intimp.2024.112331_b0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1248\/bpb.b23-00768","article-title":"Steroid-insensitive gene expression of extracellular matrix components and pro-fibrotic factors in the lung associated with airway hyperresponsiveness in murine asthma","volume":"47","author":"Shimora","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2024.112331_b0255","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1183\/09031936.00007306","article-title":"Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling","volume":"30","author":"Walters","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2024.112331_b0260","doi-asserted-by":"crossref","unstructured":"H. Shimora, M. Matsuda, Y. Nakayama, H. Maeyama, R. Tanioka, Y. Tanaka, K. Kitatani, T. Nabe, Involvement of Janus kinase (JAK)-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells (ILC2s) in asthma, Immunology in press (2024).","DOI":"10.1111\/imm.13805"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:42:40Z","timestamp":1762551760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924008518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"alternative-id":["S1567576924008518"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112331","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112331"}}